A “superresponse” to cardiac resynchronization therapy in patients with chronic heart failure

Kuznetsov, V.A.; Melnikov, N.N.; Krinochkin, D.V.; Soldatova, A.M.; Enina, T.N.

doi:10.18087/rhfj.2015.3.2069

RHFJ

2015

DOI: 10.18087/rhfj.2015.3.2069

|View full text |Cite

A “superresponse” to cardiac resynchronization therapy in patients with chronic heart failure

V.A. Kuznetsov¹,

N.N. Melnikov²,

D.V. Krinochkin³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Accumulated experience of implanting CRT devices suggests that the response to CRT and the timing of the response vary between individual patients. Some patients show an early response to CRT with significant improvements in clinical and functional parameters within the first 3 months after device implantation (2). By contrast, other patients show later responses (3).…”

mentioning

confidence: 99%

Late best response to cardiac resynchronization therapy is associated with better survival of patients with congestive heart failure

Am¹,

Va²,

Dv³

et al. 2017

Curr Res Cardiol

View full text Add to dashboard Cite

OPEN ACCESSThis open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http:// creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. AIM:The aim was to evaluate clinical, morphological, functional features and mortality in patients with congestive heart failure (CHF) and different time of the best response to cardiac resynchronization therapy (CRT). MATERIALS AND METHODS:122 patients (82.8% men) with NYHA functional class III-IV (mean age 54.8 ± 9.6 years) were enrolled. At baseline, 1, 3 months and each 6 months after implantation we evaluated clinical and echocardiographic parameters. In 28 patients the best decrease of left ventricular end-systolic volume (LVESV) was achieved up to 3 months (1.1 ± 0.9 months, I group-early response) and in 94 patients-after 3 months (22.6 ± 14.9 months, II group-late response). RESULTS:At baseline groups did not differ in main clinical characteristics, the proportion of atrial fibrillation, the presence of left bundle-branch block (LBBB), width of the QRS complex and parameters of mechanical dyssynchrony. Level of left ventricular ejection fraction (LVEF) and left ventricular volumes were comparable between groups. In the II group responders (decrease in LVESV ≥ 15%) were identified more frequently (90.4% vs. 60.7%; p=0.001), all patients with decrease of LVESV ≥ 30% (super responders) had late response.During follow-up period (33.2 ± 16.7 months) increase in LVEF and decrease in LVESV were more evident in patients with late response.In Kaplan-Meier analysis mortality in II group was significantly lower (3.2% vs 28.6%; p=0.001). Cox regression showed that LVESV (HR 1.012; 95% CI 1.004-1.021; P=0.005) and the time of response (HR 0.131; 95% CI 0.032-0.530; P=0.004) were associated with long-term mortality. CONCLUSION:Patients with early response to CRT show significantly lower improvement in LVEF and LVESV compared to patients with late CRT response. Super respone to CRT in associated with late functional improvement. Early response and greater LVESV are associated with higher mortality rate.

show abstract

mentioning

confidence: 99%

Late best response to cardiac resynchronization therapy is associated with better survival of patients with congestive heart failure

Am¹,

Va²,

Dv³

et al. 2017

Curr Res Cardiol

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

A “superresponse” to cardiac resynchronization therapy in patients with chronic heart failure

Cited by 1 publication

References 25 publications

Late best response to cardiac resynchronization therapy is associated with better survival of patients with congestive heart failure

Late best response to cardiac resynchronization therapy is associated with better survival of patients with congestive heart failure

Contact Info

Product

Resources

About